Integrated Filing — IndAS



General information about company

Scrip Code 506109
NSE Symbol GENESYS
MSEI Symbol NOTLISTED
ISIN INE727B01026
Name of company Genesys International Corporation Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 13-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 06-11-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Geographical information system
Start date and time of board meeting 13-11-2025   16:10:00
End date and time of board meeting 13-11-2025   17:15:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 14-02-2025
Indicate Company website link for updated RPT policy of the Company www.igenesys.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
no default on loans



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 5,992.12 12,734.58
Other income 392.18 527.98
Total income 6,384.30 13,262.56
2 Expenses
(a) Cost of materials consumed 2,211.96 3,781.26
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0.00 0.00
(d) Employee benefit expense 1,568.33 3,219.51
(e) Finance costs 310.37 628.66
(f) Depreciation, depletion and amortisation expense 914.94 1,834.16
(f) Other Expenses
1 Other Expenses 538.64 1,107.51
Total other expenses 538.64 1,107.51
Total expenses 5,544.24 10,571.10
3 Total profit before exceptional items and tax 840.06 2,691.46
4 Exceptional items 0.00 0.00
5 Total profit before tax 840.06 2,691.46
6 Tax expense
7 Current tax 223.27 736.12
8 Deferred tax 2.00 7.00
9 Total tax expenses 225.27 743.12
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 614.79 1,948.34
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 614.79 1,948.34
17 Other comprehensive income net of taxes 18.15 15.77
18 Total Comprehensive Income for the period 632.94 1,964.11
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 2,085.95 2,085.95
Face value of equity share capital 5 5
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 1.47 4.73
Diluted earnings (loss) per share from continuing operations 1.47 4.71
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.47 4.73
Diluted earnings (loss) per share from continuing and discontinued operations 1.47 4.71
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) The Statement has been prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 Interim Financial Reporting prescribed under Section 133 of the Companies Act 2013 as amended read with relevant rules there under and in terms of Regulation 33 of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements Regulations 2015 as amended The unaudited standalone financial results for the quarter and half year ended 30 September 2025 were reviewed by the Audit Committee and approved by the Board of Directors of Genesys International Corporation Limited the Company at their respective meeting held on November 13 2025 and are available on the company website and BSE and NSE website The statutory auditor of the company have carried out limited review on the above results in terms of regulation 33 of the SEBI Listing Obligation and Disclosure Requirements Regulations 2015 the Regulation as amended and expressed an unmodified review conclusion On 17th May 2025 the Company has by way of Qualified Institutional Placement QIP in accordance with SEBI Issue of Capital and Disclosure Requirements Regulations 2018 as amended and section 42 and 62 of the Companies Act 2013 allotted 1739625 equity shares of face value of Rs 5 per share at a price of Rs632.32 per share aggregating to Rs11000 lakhs The funds raised by the Company pursuant to QIP have been partially utilized in accordance with the Use of Proceeds mentioned in the placement document of QIP for the period ended 30th September 2025 and unutilized balances as at 30th September 2025 have been temporarily invested Previous period figures have been regrouped re-classified wherever necessary



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 5,495.81
Capital work-in-progress 362.21
Investment property 0.00
Goodwill 0.00
Other intangible assets 751.76
Intangible assets under development 16,411.47
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 13,647.16
Trade receivables, non-current
Loans, non-current 24.80
Other non-current financial assets 2,199.81
Total non-current financial assets 15,871.77
Deferred tax assets (net) 1,118.04
Other non-current assets 1,487.19
Total non-current assets 41,498.25
2 Current assets
Inventories 0.00
Current financial asset
Current investments 0.00
Trade receivables, current 17,731.48
Cash and cash equivalents 2,754.17
Bank balance other than cash and cash equivalents 7,550.70
Loans, current 586.65
Other current financial assets 25,341.94
Total current financial assets 53,964.94
Current tax assets (net) 97.85
Other current assets 2,446.86
Total current assets 56,509.65
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 98,007.90
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 2,085.95
Other equity 72,568.81
Total equity attributable to owners of parent 74,654.76
Non controlling interest
Total equity 74,654.76
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 918.19
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 551.90
Total non-current financial liabilities 1,470.09
Provisions, non-current 996.75
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities 0.00
Total non-current liabilities 2,466.84
Current liabilities
Current financial liabilities
Borrowings, current 12,702.46
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 522.10
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 2,934.62
Total Trade payable 3,456.72
Other current financial liabilities 3,319.27
Total current financial liabilities 19,478.45
Other current liabilities 486.77
Provisions, current 248.30
Current tax liabilities (Net) 672.78
Deferred government grants, Current 0.00
Total current liabilities 20,886.30
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 23,353.14
Total equity and liabilites 98,007.90
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of net defined benefit plans (net of taxes) 1815000 1577000
Total Amount of items that will not be reclassified to profit and loss 18.15 15.77
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 18.15 15.77



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 2,691.46
Adjustments for reconcile profit (loss)
Adjustments for finance costs 628.66
Adjustments for decrease (increase) in inventories 0.00
Adjustments for decrease (increase) in trade receivables, current 2,144.73
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (1,762.29)
Adjustments for decrease (increase) in other non-current assets (206.69)
Adjustments for other financial assets, non-current (49.80)
Adjustments for other financial assets, current (3,415.99)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (177.34)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (246.98)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 1,834.16
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 15.49
Adjustments for provisions, non-current 50.38
Adjustments for other financial liabilities, current 97.84
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (22.67)
Adjustments for dividend income 0.00
Adjustments for interest income 290.91
Adjustments for share-based payments 103.63
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 178.06
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (1,119.72)
Net cash flows from (used in) operations 1,571.74
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 1,455.22
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 116.52
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 37.97
Purchase of property, plant and equipment 1,153.50
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 40.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 1,215.33
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 197.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (7,610.78)
Net cash flows from (used in) investing activities (9,784.64)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 10,353.14
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 134.62
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 3,177.34
Repayments of borrowings 512.63
Payments of lease liabilities 280.52
Dividends paid 0.00
Interest paid 561.36
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 12,310.59
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 2,642.47
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 2,642.47
Cash and cash equivalents cash flow statement at beginning of period 111.70
Cash and cash equivalents cash flow statement at end of period 2,754.17





Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising QIP
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 17-05-2025
Amount Raised 11,000.00
Report filed for Quarter ended 30-09-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable CARE Ratings Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review None
Comments of the auditors, if any
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Setting up of data centre No 1,770.50 0.00 0.00 0.00
2 Development of tech platform No 2,574.22 0.00 141.98 0.00
3 Creation/updation of map content No 1,865.16 0.00 0.00 0.00
4 Building sensor capacity No 1,056.83 0.00 0.00 0.00
5 Strengthening information technology infrastructure No 983.34 0.00 0.00 0.00
6 General corporate purposes No 2,049.15 0.00 1,950.00 0.00
7 Issue Expenses No 700.80 0.00 646.98 0.00


Signatory Details

Name of signatory Kushal Jain
Designation of person Company Secretary and Compliance Officer
Place Mumbai
Date 13-11-2025




Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Genesys International Corporation Limited Mr. Sajid Siraj Malik Chairman & Managing Director Remuneration Remuneration is as per the Companies Act 2013 and Shareholders Approval 42.00 0.00 2.00
2 Genesys International Corporation Limited Mr. Manish Patel Non executive Independent Director Any other transaction Sitting fees As per the Companies Act 2013 0.05 0.09 0.00
3 Genesys International Corporation Limited Ms. Bharti Sinha Non executive Independent Director Any other transaction Sitting fees As per the Companies Act 2013 0.40 0.05 0.00
4 Genesys International Corporation Limited Mr. Ajay Harish Aggarwal Non executive Independent Director Any other transaction Sitting fees As per the Companies Act 2013 0.35 0.07 0.00
5 Genesys International Corporation Limited Dr. Yogita Shukla Non executive Non Independent Director Any other transaction Sitting fees As per the Companies Act 2013 0.03 0.08 0.00
6 Genesys International Corporation Limited Mr. Omprakash Sanwaldas Hemrajani Non executive Non Independent Director Any other transaction Sitting fees As per the Companies Act 2013 0.28 0.11 0.00
7 Genesys International Corporation Limited Mr. Omprakash Sanwaldas Hemrajani Non executive Non Independent Director Any other transaction Consultancy fees 60.00 approved by the Audit committee 30.00 4.50 5.50
8 Genesys International Corporation Limited Mrs. Sunita Hemrajani Relative of Director Any other transaction Consultancy fees 60.00 approved by the Audit committee 30.00 4.34 5.66
9 Genesys International Corporation Limited AddGeo Foundation Company in which Common Directorship Any other transaction Consultancy fees 12.00 approved by the Audit committee 1.86 0.81 0.00
10 Genesys International Corporation Limited Mr.Vineet Chopra Company Secretary Remuneration not applicable 17.78 2.16 0.00 Textual Information(1)
11 Genesys International Corporation Limited Mr. Kushal Jain Company Secretary and Compliance Officer Remuneration not applicable 7.69 0.00 1.62 Textual Information(2)
12 Genesys International Corporation Limited Mr. Kushal Jain Company Secretary and Compliance Officer Any other transaction ESOP expense not applicable 3.18 0.00 0.00 Textual Information(3)
13 Genesys International Corporation Limited Mr Ravi Jatavallabha V Chief Financial Officer Remuneration not applicable 62.27 6.12 6.99
14 Genesys International Corporation Limited Mr Ravi Jatavallabha V Chief Financial Officer Any other transaction Advance adjusted 10.00 approved by the Audit committee 1.28 5.71 4.43 Advance 0.00 3 years Unsecured Salary advance
15 Genesys International Corporation Limited Mr Ravi Jatavallabha V Chief Financial Officer Any other transaction ESOP expense not applicable 24.75 0.00 0.00
16 Genesys International Corporation Limited Mr. Sajid Siraj Malik Chairman & Managing Director Any other transaction Loan Received 2,500.00 approved by the Audit committee 1,515.00 0.00 1,240.00 Loan 0.00 Repayable on demand Unsecured Working capital
17 Genesys International Corporation Limited Mr. Sajid Siraj Malik Chairman & Managing Director Any other transaction Loan Repaid 2,500.00 approved by the Audit committee 275.00 0.00 1,240.00 Loan 0.00 Repayable on demand Unsecured Working capital
18 Genesys International Corporation Limited Mr. Omprakash Sanwaldas Hemrajani Non executive Non Independent Director Any other transaction Loan Received 2,500.00 approved by the Audit committee 0.00 1,100.00 1,100.00 Loan 0.00 Repayable on demand Unsecured Working capital
19 Genesys International Corporation Limited Mr. Omprakash Sanwaldas Hemrajani Non executive Non Independent Director Any other transaction Loan Repaid 2,500.00 approved by the Audit committee 0.00 1,100.00 1,100.00 Loan 0.00 Repayable on demand Unsecured Working capital
20 Genesys International Corporation Limited Valeo Nutra Private Limited Company in which Common Directorship Any other transaction Interest Payable 237.60 approved by the Audit committee 47.44 12.55 55.24 Loan 12.00 Repayable on demand Unsecured Working capital
21 Genesys International Corporation Limited Valeo Nutra Private Limited Company in which Common Directorship Any other transaction Loan Repaid 1,980.00 approved by the Audit committee 50.00 800.00 750.00 Loan 12.00 Repayable on demand Unsecured Working capital
22 Genesys International Corporation Limited A.N Virtual World Tech Limited Subsidiary Investment not applicable 0.00 7,399.40 7,399.40
23 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Loan not applicable 307.69 451.36 583.05 Loan 8.00 3 years Unsecured Working capital
24 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Any other transaction Loan returned not applicable 175.27 451.36 583.05 Loan 8.00 3 years Unsecured Working capital
25 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Interest received not applicable 16.41 7.93 7.52
26 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Any other transaction Project Expenses not applicable 409.32 230.26 307.01
27 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Sale of goods or services not applicable 214.10 2,336.77 2,228.87
28 Genesys International Corporation Limited Genesys Middle East Company Limited Wholly owned Subsidiary Investment not applicable 0.00 312.37 312.37
29 Genesys International Corporation Limited A.N Virtual World Tech Limited Subsidiary Any other transaction Provision for impairment of investments 8,569.79 approved by the Audit committee 0.00 8,569.79 8,569.79
30 Genesys International Corporation Limited A.N Virtual World Tech Limited Subsidiary Investment not applicable 0.00 14,505.18 14,505.18
31 Genesys International Corporation Limited Late Mrs. Saroja Siraj Malik Whole-time Director Remuneration Remuneration is as per the Companies Act 2013 and Shareholders Approval 0.00 0.32 0.32
Total value of transaction during the reporting period 3,232.15



Text Block

Textual Information(1) Company Secretary upto 31 may 2025
Textual Information(2) Company Secretary with effect from 1st June 2025
Textual Information(3) Company Secretary with effect from 1st June 2025